Intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm

Completed

Phase N/A Results

Summary of Purpose

To study the possible role of intracisternally administered fibrinolytic agent recombinant tissue plasminogen activator (rt-PA) in preventing delayed onset cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 July 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled trial of 100 patients at 9 centers.

Contacts

Not available